Treatment of hypertensive and hypercholesterolaemic patients in general practice: The effect of captopril, atenolol and pravastatin combined with life style intervention

Scandinavian Journal of Primary Health Care

Volumn 17, Issue 2, 1999, Pages 122-127

  Foss, Olav Per ^a   Graff Iversen, Sidsel ^b   Istad, Helge ^c   Søyland, Einar ^d   Tjeldflaat, Leiv ^e   Graving, Bjørn ^f  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b National Health Screening Service   (Norway)

^c Theresesgt Legesenter   (Norway)

^d VESTRE VIKEN HOSPITAL TRUST   (Norway)

^e Moss Legegruppe ^*  (Norway)

^f BRISTOL MYERS SQUIBB   (United States)

Author keywords

Atenolol; Blood pressure; Captopril; Cholesterol; Lifestyle; Lipids; Pravastatin

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PRAVASTATIN; TRIACYLGLYCEROL;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BEHAVIOR MODIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; GENERAL PRACTICE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFESTYLE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NORWAY; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICHOLESTEREMIC AGENTS; ATENOLOL; CAPTOPRIL; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFE STYLE; MALE; MIDDLE AGED; NORWAY; PRAVASTATIN; STATISTICS, NONPARAMETRIC;

EID: 0032800746     PISSN: 02813432     EISSN: None     Source Type: Journal    
DOI: 10.1080/028134399750002764     Document Type: Article

References (18)

1. Hjermann I. Smoking and diet intervention in coronary high risk men. Methods and 5-year follow up of risk factors in a randomized trial. The Oslo Study. J Oslo City Hosp 1980;30:3-17.
2. Fagerberg B, Andersson OK, Isaksson B, Björntorp P. Blood pressure control during body weight reduction in obese hypertensive men: separate effects of sodium and energy restriction. BMJ 1984;288:11-4.
3. Kaplan NM. Non-drug treatment of hypertension. Ann Intern Med 1985;102:359-73.
4. Leren P, Helgeland A, Holme I, Foss OP, Hjermann I, Lund-Larsen PG. Effect of propranolol and Prazosin on blood lipids. The Oslo Study. Lancet 1980;5:4-6.
5. Leren P, Foss OP, Helgeland A, Hjerman I, Holme I. Effects of pindolol and hydrochlorothiazide on blood lipids. The Oslo Study. Clin Trials J 1980;13:254-61.
6. Rouffy J, Jailard J. Comparative effect of prazosin and atenolol on plasma lipids in hypertensive patients. Am J Med 1984;76:105-8.
7. Weidman P, Uehlinger DE, Gerber A. Editorial Review: Antihypertensive treatment and serum lipoproteins. J Hypertens 1985;3:297-306.
8. Sasaki J, Arakawa K. Effect of captopril on serum lipids, lipoproteins and apolipoproteins in patients with mild essential hypertension. Curr Ther Res Clin Exp 1986;40:898-902.
9. Talseth T, Westlie L, Daae L, Vatle S. Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: A one-year, double-blind study in 228 hypertensive patients. Am Heart J 1988;116:1790-6.
10. Birkebæk NH, Gerdes LU, Nielsen A, Færgeman O, Vejby-Christensen H. Effect of nifedipine and captopril on plasma lipoproteins in hypertensive patients. Curr Ther Res Clin Exp 1989;46:619-24.
11. Foss OP, Jensen K. The effect of captopril and metoprolol as monotheraphy or combined with bendroflumethiazide on blood lipids. J Int Med 1990;227:119-23.
12. Yoshino G, Kazumi R, Uenoyama R, Morita S, Inui A, Kasama T, et al. Effect of eptastatin (CS-514) on hypercholesterolemic patients. Curr Ther Res Clin Exp 1986;40:1017-21.
13. Saku K, Sasaki J, Arakawa K. Long-term effect of CS-514 (HMG-CoA reductase inhibitor) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia. Curr Ther Res Clin Exp 1987;42:491-500.
14. Hoeg JM, Brewer HB. 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of hypercholesterolemia. JAMA 1987;258:3532-6.
15. Yoshino G, Matsushita M, Iwai M, Uenoyama R, Matsuba K, Morita M, et al. Two-year study on the effect of pravastatin (CS-514) on plasma lipoprotein and apolipoprotein concentrations in hypercholesterolemic patients. Curr Ther Res Clin Exp 1989;46:144-52.
16. Kushner RF. Body weight and mortality. Nutr Rev 1993;51:127-36.
17. 1989 Guidelines for the management of mild hypertension: Memorandum from WHO/ISH meeting. Bull World Health Organ 1989;67:493-8.
18. Andrén L, Karlberg BE, Svensson A, Öhman P, Nilsson OR, Hansson L. Long-term effects of captopril and atenolol in essential hypertension. Acta Med Scand 1985;217:155-60.